Blocking 'engulfment' gives dying cells new lease on life

July 11, 2001

Multicellular life is a balance between cell survival and cell death. The genetically programmed death of cells is a normal part of embryonic development and occurs throughout the lifetime of organisms to rid abnormal (e.g. pre-cancerous) and surplus cells from the body. Research at Cold Spring Harbor Laboratory now reveals that under special circumstances, cells programmed to die during nervous system development can be brought back from the brink of death. This finding has important implications for the treatment of neurodegenerative disease, stroke, and cancer.

The study, to be published July 12 in Nature, focused on the developing nervous system of a favored experimental organism: the soil nematode worm Caenorhabditis elegans. Cell survival and cell death during development in this animal is highly stereotyped. Among different embryos, cells in corresponding positions virtually always share the same fate. Because the worms are transparent, the fate of all cells--living, dead, or dying--can be followed relatively easily and filmed by using a video camera attached to a microscope.

Under normal circumstances, dead cells are engulfed by neighboring cells to eliminate them from the embryo. Until now, the engulfment process was viewed as an after-the-fact, disposal operation. Cold Spring Harbor Laboratory researchers Daniel Hoeppner and Michael Hengartner, together with Ralf Schnabel of the Institute for Genetics (Braunschweig, Germany), studied how the death and "burial" (engulfment) processes are coördinated during development of the C. elegans nervous system. They made two interesting discoveries.

First, the scientists found that when they weakened the genetically programmed signal for cells to die, most cells still died (65%) and an expected cohort of cells survived (15%). Surprisingly, however, a few cells (5%) proceeded all the way to death's door but at the very last stage before death (stage 3 of 4), they reverted to a normal appearance and survived.

Second, the researchers found that blocking engulfment in animals with a genetically weakened cell death signal increased the number of cells that escaped death to nearly 20%. Moreover, some 40% of cells slated for death in these animals survived outright, never displaying signs of death. In essence, when the engulfment machinery was disabled, cells lived that otherwise would have died. This finding indicates that the engulfment machinery actively contributes to cell killing, rather than merely eliminating dead cells.

Because many features of programmed cell death and engulfment are conserved between C. elegans and humans, the scientists suggest that modulating the activity of the engulfment machinery in humans might be an effective therapy for neurodegenerative disease, stroke, and cancer.
Daniel Hoeppner is currently at the National Institutes of Health (Bethesda, Maryland). Michael Hengartner is currently at the University of Zurich (Zurich, Switzerland).

Cold Spring Harbor Laboratory

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to